World of Bacteria header image

Staphylococcus simulans

Staphylococcus simulans is a coagulase-negative staphylococcal species that may be associated with animals but is also occasionally recovered from human clinical material, where visibly haemolytic isolates can resemble more familiar pathogenic staphylococci on blood agar.

Basic Characteristics

Taxonomy

  • Domain: Bacteria
  • Phylum: Bacillota (Firmicutes)
  • Class: Bacilli
  • Order: Bacillales
  • Family: Staphylococcaceae
  • Genus: Staphylococcus
  • Species: Staphylococcus simulans

Microscopy & Gram Stain

  • Gram-positive cocci
  • Cells occur singly, in pairs, and in irregular clusters
  • Microscopic morphology is typical of staphylococci but not species-specific

Oxygen Relationship

  • Facultatively anaerobic
  • Grows readily under routine aerobic blood agar conditions
  • Not regarded as a fastidious species in routine laboratory work

Rapid Identification Tests

  • Catalase: positive
  • Coagulase: negative
  • Colony pigmentation: usually absent or weak
  • Haemolysis on blood agar: variable, often weak or absent but occasionally conspicuous

Ecology and Clinical Relevance

Natural Habitat

  • Originally described from human skin
  • Also recognized as an animal-associated staphylococcal species, especially in veterinary microbiology
  • Human recovery appears less common than for major skin-colonizing coagulase-negative staphylococci

Common Clinical Specimens

  • Wound swabs and skin or soft tissue material
  • Occasional urine specimens
  • Blood culture and device-associated material in uncommon cases
  • Veterinary specimens, particularly those linked to livestock

Clinical Significance

  • Uncommon opportunistic pathogen in humans
  • Better known as an animal-associated species, including in bovine mastitis
  • May cause skin and soft tissue infection, urinary infection, or other invasive disease in selected cases
  • Can be overlooked or underestimated when isolated together with more familiar skin flora

Differential Considerations

  • Staphylococcus epidermidis, because both may occur in mixed skin-associated cultures
  • Staphylococcus haemolyticus, because both are coagulase-negative and may show haemolysis
  • Staphylococcus aureus, when haemolysis on blood agar is prominent
  • Species-level identification should not rely on morphology alone

Diagnostic and Clinical Notes

Staphylococcus simulans is an instructive species because the organism is usually discussed as an uncommon human pathogen, yet in some isolates the plate phenotype is unexpectedly striking. In this case, the isolate showed clear haemolysis already after 24 hours, which can easily draw attention toward more familiar haemolytic staphylococci.

The specimen context is also important. The isolate came from a wound in a patient treated in a surgical intensive care unit and became more evident only after subculture from enrichment broth. In the primary culture it was present only sporadically, reminding us that potentially relevant organisms may be underrepresented at first reading.

This culture is visually mixed, with haemolytic colonies of S. simulans present together with non-haemolytic colonies of Staphylococcus epidermidis. Such combinations are diagnostically useful because they highlight how strongly haemolysis can influence the visual impression of a mixed plate.

Although S. simulans is best known from veterinary microbiology, especially in animal-associated infections, it should not be dismissed automatically when recovered from human clinical material. Human infections are uncommon but well documented, including skin and soft tissue infection and occasional invasive disease.

The MALDI-TOF MS score of 2.54 is a particularly strong point in this case. For less familiar coagulase-negative staphylococci, reliable modern identification is essential because morphology alone does not securely separate them from better known species.

Laboratory Identification

Colony Morphology

On blood agar, Staphylococcus simulans forms smooth, convex, round colonies with entire margins. The colonies in this page set are non-pigmented but surrounded by a conspicuous zone of beta-haemolysis. This is diagnostically noteworthy because many isolates of S. simulans show only weak haemolysis or none at all, and stronger haemolysis may therefore create a misleading first impression.

Microscopy

Gram staining shows Gram-positive cocci occurring singly, in pairs, and in clusters. This microscopic pattern is entirely compatible with the genus Staphylococcus but does not allow reliable distinction of S. simulans from other coagulase-negative or even more familiar haemolytic staphylococci.

Key Identification Clues

  • Gram-positive cocci in clusters
  • Catalase positive
  • Coagulase negative
  • Usually non-pigmented colonies
  • Haemolysis may be weak, absent, or occasionally pronounced
  • May occur in mixed cultures and be overlooked in primary material
  • MALDI-TOF MS is highly useful for reliable species-level identification

Modern Identification Methods

Species-level identification is best supported by MALDI-TOF mass spectrometry with an up-to-date database, or by molecular methods if needed. In this isolate, MALDI-TOF MS yielded a score of 2.54, supporting highly reliable identification. This is especially valuable for S. simulans because phenotypic overlap with other coagulase-negative staphylococci can be substantial.

Antibiotic Characteristics

Staphylococcus simulans should not be assigned a susceptibility pattern on the basis of species name or colony appearance alone. As with other coagulase-negative staphylococci, antimicrobial susceptibility may vary from isolate to isolate.

When the species is recovered from human clinical material, susceptibility testing should be performed on the individual isolate and interpreted together with the specimen type, the amount of growth, and the broader clinical context.

In mixed cultures, therapeutic interpretation is especially dependent on deciding whether S. simulans is acting as a true pathogen, a copathogen, or a less significant accompanying organism.

Note: Antimicrobial therapy should always be guided by laboratory susceptibility testing, specimen context, and overall clinical evaluation.

External Resources

For broader general information about Staphylococcus simulans, see: